Clorazepate Dipotassium Tablet
Product Images NDC 72789-256

2 FDA label images from Pd-rx Pharmaceuticals, Inc. · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Clorazepate Dipotassium (NDC 72789-256). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Pd-rx Pharmaceuticals, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

72789256 Label (72789256)

72789256 Label (72789256)
Label for Clorazepate Dipotassium USP 15 mg oral tablets containing 6 tablets per package. The label includes the NDC 72789-256-06, manufacturer PD-Rx Pharmaceuticals, Inc., and indicates the product is prescription only. It also features warnings about side effects, federal transfer restrictions, and storage instructions.*
FDA Label Image

Chemical Structure (Clorazepate 01)

Chemical Structure (Clorazepate 01)
Chemical structure of Clorazepate Dipotassium, shown with its molecular framework including a benzodiazepine core, chlorinated aromatic ring, and potassium hydroxide (KOH) component.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.